.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Fuji
Mallinckrodt
Novartis
Moodys
QuintilesIMS
US Department of Justice
Chubb
Queensland Health
US Army

Generated: September 21, 2017

DrugPatentWatch Database Preview

Bepridil hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for bepridil hydrochloride and what is the scope of bepridil hydrochloride patent protection?

Bepridil hydrochloride
is the generic ingredient in two branded drugs marketed by Medpointe Pharm Hlc and Johnson And Johnson, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for bepridil hydrochloride.

Summary for Generic Name: bepridil hydrochloride

Tradenames:2
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list4
Bulk Api Vendors: see list49
Clinical Trials: see list2,278
Patent Applications: see list4,957
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:bepridil hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-001Dec 28, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
BEPADIN
bepridil hydrochloride
TABLET;ORAL019001-002Dec 28, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-002Dec 28, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-003Dec 28, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
BEPADIN
bepridil hydrochloride
TABLET;ORAL019001-001Dec 28, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Medpointe Pharm Hlc
BEPADIN
bepridil hydrochloride
TABLET;ORAL019001-003Dec 28, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: bepridil hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medpointe Pharm Hlc
BEPADIN
bepridil hydrochloride
TABLET;ORAL019001-001Dec 28, 1990► Subscribe► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-002Dec 28, 1990► Subscribe► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-001Dec 28, 1990► Subscribe► Subscribe
Medpointe Pharm Hlc
BEPADIN
bepridil hydrochloride
TABLET;ORAL019001-003Dec 28, 1990► Subscribe► Subscribe
Medpointe Pharm Hlc
BEPADIN
bepridil hydrochloride
TABLET;ORAL019001-002Dec 28, 1990► Subscribe► Subscribe
Johnson And Johnson
VASCOR
bepridil hydrochloride
TABLET;ORAL019002-003Dec 28, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Harvard Business School
McKinsey
AstraZeneca
Colorcon
Cantor Fitzgerald
US Army
Baxter
Moodys
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot